Diamond Hill Capital’s Top Stock Picks

Ric Dillon is head honcho at the $8+ billion Diamond Hill Capital Management. The firm is publicly traded on the NASDAQ under the ticker DHIL and is part of the Russell 2000 Index. Diamond Hill takes long-term approach to capital management and believes heavily in the concept of reversion to intrinsic value. In this article we will take a closer look at Diamond Hill Capital’s top stock picks:

CompanyName Ticker Value Activity
OCCIDENTAL PETROLEUM CORP OXY 279521 -2%
ANADARKO PETROLEUM CORP APC 258996 -1%
UNITED TECHNOLOGIES CORP UTX 246877 -2%
ABBOTT LABORATORIES ABT 226778 -2%
PFIZER INC PFE 213616 -1%
MEDTRONIC INC MDT 210037 -2%
PROCTER & GAMBLE CO PG 205784 1%
MICROSOFT CORP MSFT 192065 -7%
PEPSICO INC PEP 191440 -4%
P N C FINANCIAL SERVICES GRP PNC 181597 -3%

Occidental Petroleum Corporation (NYSE:OXY)

Occidental Petroleum (NYSE: OXY) has been lagging in recent history. We too have not been thrilled by capital spending overruns and awful reserve replacements in the past year and a half. To stem the bloodshed, the company has made a couple moves. It hired a new EVP of Operations, Willie Chiang. He was rumored to be in the running for the top job at Phillips 66 but that went to Greg Garland. Chiang’s expertise has been in refining, so we’re not sure how that will translate into better performance at OXY but we’ll just have to see. With shares below $80, we thought the company would be buying back shares like mad. However, this has not materialized. In Q1 calls, CEO Chazen did indicate that buybacks would take place, and we think they will. If share repurchases get OXY to a 7% cash yield this year, there is no way the stock should trade below $80, especially with improvements in California. We’re in as are Ralph Whitworth, Leighton Welch, and Robert Bishop.

Anadarko Petroleum (NYSE: APC) has been operating smoothly thus far with decent FCF generation. The stock is trading relatively in line with its large cap peers. And though we think there are additional unlocked sources of value in West Africa (offshore), the Gulf of Mexico, and other resource play programs, until the Tronox trial is over, we would not recommend establishing a position. In this $25 billion environmental lawsuit, Tronox and the US government are up against APC and Kerr-McGee that will assign blame for Tronox’s “toxic past.” Chemical maker, Tronox, had filed for Chapter 11 in 2009. In terms of what investors expect, according to a Credit Suisse survey, 65% of respondents believe the valuation embeds more than $1.5 billion for Tronox, including 31% between $1.5 and $2.5 billion and 34% above $2.5 billion. APC management does not seem to want to settle, so we expect this to get dirty.

United Technologies (NYSE: UTX) is an industrial conglomerate with brands like Otis (world’s largest elevator company), Carrier (commercial/residential heating and air-conditioning systems and commercial transport refrigeration equipment), Pratt & Whitney (supplies military and civil aircraft engines and service operations), and Sikorsky (helicopters). UTX is a major player in aerospace and defense as well as global infrastructure, and we think the company can continue to post solid results accompanied by share repurchases given its substantial FCF conversion. However, we don’t see many upcoming catalysts and would prefer a global operator with more ex-US sales (UTX derives 60 percent of sales from the US).

Abbott Laboratories (NASDAQ: ABT), like other big pharma companies, faces a looming patent cliff. It currents dominates the autoimmune market, an estimated $25 billion market that includes treatment for rheumatoid arthritis, Crohn’s disease, Addison’s disease, multiple sclerosis, and type I diabetes. ABT’s Humira is the world’s best-selling drug in the autoimmune market, with an estimated market share of well over 30% (mostly to treat rheumatoid arthritis). 2011 Humira revenues were over $8 billion, and we think this could accelerate to $10.5 billion by 2013. However, ABT’s HIV antiviral, Kaletra, has been losing market share in part because of exclusion from the list of preferred treatment options in some US Department of Health and Human Services’ (DHHS) guidelines. Overall ABT has a decent pipeline but we prefer pharma companies with catalysts and a strong pipeline like Pfizer (read more on Why Hedge Funds Love Pfizer).

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Bloodiest UFC Fights Ever Fought

Most Expensive Rum Brands in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!